L
Leslee J. Shaw
Researcher at Cornell University
Publications - 871
Citations - 70793
Leslee J. Shaw is an academic researcher from Cornell University. The author has contributed to research in topics: Coronary artery disease & Myocardial infarction. The author has an hindex of 116, co-authored 808 publications receiving 61598 citations. Previous affiliations of Leslee J. Shaw include Saint Louis University & Cedars-Sinai Medical Center.
Papers
More filters
Journal ArticleDOI
International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: Rationale and design.
David J. Maron,Judith S. Hochman,Sean M. O'Brien,Harmony R. Reynolds,William E. Boden,Gregg W. Stone,Sripal Bangalore,John A. Spertus,Daniel B. Mark,Karen P. Alexander,Leslee J. Shaw,Jeffrey S. Berger,T. Bruce Ferguson,David O. Williams,Robert A. Harrington,Yves Rosenberg +15 more
TL;DR: The ISCHEMIA trial will provide new scientific evidence regarding whether an invasive management strategy improves clinical outcomes when added to optimal medical therapy in patients with SIHD and moderate or severe ischemia.
Journal ArticleDOI
Optimized prognostic score for coronary computed tomographic angiography: results from the CONFIRM registry (COronary CT Angiography EvaluatioN For Clinical Outcomes: An InteRnational Multicenter Registry)
Martin Hadamitzky,Stephan Achenbach,Mouaz H. Al-Mallah,Daniel S. Berman,Matthew J. Budoff,Filippo Cademartiri,Tracy Q. Callister,Hyuk Jae Chang,Victor Y. Cheng,Kavitha Chinnaiyan,Benjamin J.W. Chow,Ricardo C. Cury,Augustin Delago,Allison Dunning,Gudrun Feuchtner,Millie Gomez,Philipp A. Kaufmann,Yong Jin Kim,Jonathon Leipsic,Fay Y. Lin,Erica Maffei,James K. Min,Gil Raff,Leslee J. Shaw,Todd C. Villines,Jörg Hausleiter +25 more
TL;DR: In CCTA, both plaque burden and stenosis, particularly in proximal segments, carry incremental prognostic value and a prognostic score on the basis of this data can improve risk prediction beyond clinical risk scores.
Journal ArticleDOI
A 15-Year Warranty Period for Asymptomatic Individuals Without Coronary Artery Calcium: A Prospective Follow-Up of 9,715 Individuals
Valentina Valenti,Bríain ó Hartaigh,Ran Heo,Iksung Cho,Joshua Schulman-Marcus,Heidi Gransar,Quynh A. Truong,Leslee J. Shaw,Joseph T. Knapper,Anita A. Kelkar,Pratik B. Sandesara,Fay Y. Lin,Sebastiano Sciarretta,Hyuk Jae Chang,Tracy Q. Callister,James K. Min +15 more
TL;DR: A CAC score of 0 confers a 15-year warranty period against mortality in individuals at low to intermediate risk that is unaffected by age or sex, and in individuals considered at high risk by clinical risk scores, a CAC Score of0 confers better survival than in Individuals at low-to- intermediate risk but with any CAC scores.
Journal ArticleDOI
Role of Noninvasive Testing in the Clinical Evaluation of Women With Suspected Ischemic Heart Disease A Consensus Statement From the American Heart Association
Jennifer H. Mieres,Martha Gulati,Noel Bairey Merz,Daniel S. Berman,Thomas C. Gerber,Sharonne N. Hayes,Christopher M. Kramer,James K. Min,L. Kristin Newby,J.V. (Ian) Nixon,Monvadi B. Srichai,Patricia A. Pellikka,Rita F. Redberg,Nanette K. Wenger,Leslee J. Shaw +14 more
TL;DR: The present statement provides an update to the 2005 document and synthesizes contemporary evidence on appropriate symptomatic female candidates for diagnostic testing, as well as sex-specific data on the diagnostic and prognostic accuracy for exercise treadmill testing with electrocardiography and stress echocardiography.
Journal ArticleDOI
Comparison of risk stratification with pharmacologic and exercise stress myocardial perfusion imaging: A meta-analysis
TL;DR: This meta-analysis shows that exercise stress MPI and pharmacologicstress MPI are comparable in their ability to risk-stratify patients, however, patients undergoing pharmacologic stress studies are at a higher risk for subsequent cardiac events.